| Primary |
| Anaesthesia |
50.0% |
| Drug Use For Unknown Indication |
50.0% |
|
|
| Secondary |
| Anaesthesia |
21.8% |
| Drug Use For Unknown Indication |
21.0% |
| Product Used For Unknown Indication |
16.0% |
| General Anaesthesia |
7.4% |
| Maternal Exposure Timing Unspecified |
6.3% |
| Induction Of Anaesthesia |
6.0% |
| Sedation |
5.7% |
| Antibiotic Prophylaxis |
2.5% |
| Premedication |
2.2% |
| Blepharoplasty |
1.8% |
| Infection |
1.4% |
| Scoliosis Surgery |
1.2% |
| Surgery |
1.2% |
| Bacteroides Infection |
0.9% |
| Enterobacter Infection |
0.9% |
| Lung Disorder |
0.9% |
| Prophylaxis |
0.9% |
| Agitation |
0.8% |
| Preoperative Care |
0.6% |
| Abdominal Pain |
0.5% |
|
| Anaphylactic Shock |
11.1% |
| Shock |
9.1% |
| Rash Maculo-papular |
8.1% |
| Toxic Skin Eruption |
7.1% |
| Hypotension |
6.1% |
| Pancreatitis |
6.1% |
| Tachycardia |
6.1% |
| Rash |
5.1% |
| Somnolence |
5.1% |
| Stevens-johnson Syndrome |
5.1% |
| Cardio-respiratory Arrest |
4.0% |
| Cytolytic Hepatitis |
4.0% |
| Thrombocytopenia |
4.0% |
| Urticaria |
4.0% |
| Cardiac Arrest |
3.0% |
| Maternal Exposure Timing Unspecified |
3.0% |
| Paresis |
3.0% |
| Bradyphrenia |
2.0% |
| Condition Aggravated |
2.0% |
| Erythema |
2.0% |
|
| Concomitant |
| Sedation |
15.1% |
| Anaesthesia |
12.0% |
| Product Used For Unknown Indication |
11.1% |
| Drug Use For Unknown Indication |
10.6% |
| Pain |
9.3% |
| Prophylaxis |
4.2% |
| Infection |
3.4% |
| Unevaluable Event |
3.4% |
| General Anaesthesia |
3.1% |
| Thrombosis Prophylaxis |
3.0% |
| Gastric Cancer |
2.9% |
| Induction Of Anaesthesia |
2.9% |
| Renal Transplant |
2.9% |
| Sepsis |
2.7% |
| Septic Shock |
2.7% |
| Anxiety |
2.5% |
| Epilepsy |
2.5% |
| Vasoconstriction |
2.2% |
| Premedication |
1.8% |
| Hypertension |
1.7% |
|
| Septic Shock |
10.6% |
| Renal Failure Acute |
8.5% |
| Tachycardia |
8.5% |
| Pancreatitis |
7.4% |
| Toxic Skin Eruption |
7.4% |
| Thrombocytopenia |
6.4% |
| Anaphylactic Shock |
4.3% |
| Hypotension |
4.3% |
| Multi-organ Failure |
4.3% |
| Rash Erythematous |
4.3% |
| Shock Haemorrhagic |
4.3% |
| Sinus Bradycardia |
4.3% |
| Overdose |
3.2% |
| Petechiae |
3.2% |
| Pleural Effusion |
3.2% |
| Pulmonary Embolism |
3.2% |
| Pyrexia |
3.2% |
| Shock |
3.2% |
| Urinary Tract Infection |
3.2% |
| Urticaria |
3.2% |
|
| Interacting |
| Product Used For Unknown Indication |
30.0% |
| Schizophrenia |
20.0% |
| Anaesthesia |
15.0% |
| Drug Dependence |
10.0% |
| Mental Disorder |
10.0% |
| Sedation |
10.0% |
| Premedication |
5.0% |
|
| Drug Interaction |
50.0% |
| Ischaemic Stroke |
16.7% |
| Respiratory Arrest |
16.7% |
| Toxicity To Various Agents |
16.7% |
|
